EYES - Vision Twenty-One Inc.

4.14
-0.010   -0.242%

Share volume: 0
Last Updated: 08-31-2022

PREVIOUS CLOSE
CHG
CHG%
$4.15
-0.01
-0.24%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$4.14
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
-$1.15
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
163.154 M
YIELD 
N/A
SHARES OUTSTANDING 
39.409 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.21
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website:
Employees: 12
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California.

Recent news